GENEVA—Reviews of CD8-positive T-cell infiltration as an independent prognostic biomarker in resected non-small cell lung cancer, and the potential of checkpoint inhibitor therapy for mesothelioma after first or second line chemotherapy were presented at the European Lung Cancer Conference by Martin Reck MD PhD, from the Lung Clinic Grosshansdorf in Germany. He discussed the clinical implications with Oncology Times reporter Peter Goodwin.
CD8+ Cell Infiltration for Prognosis in Non-Small Cell Lung Cancer; Checkpoint Inhibition 2nd/3rd-line in Mesothelioma
Further reading
Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA...
Mandeep Mehra talks about his report in the New England Journal of Medicine on the inflammatory effects of COVID-19 infection and the implications...
January 2020 Pediatric Physical Therapy journal highlights the importance of non-billable tasks that are essential to achieving good outcomes. The...
SOURCE: Pediatric Physical Therapy journal ARTICLE “Trends in Attitudes and Practice Patterns of Physical Therapists in Addressing Childhood Obesity...
Uptake of the Congenital Muscular Torticollis Guidelines Survey findings about the effectiveness of a recently-introduced clinical practice guideline...
BARCELONA—A new pencil beam scanning proton delivery technique—rescanning—could help limit the dose of radiation to surrounding tissues and organs by...